Antiepileptic drugs: detection, quantification, and evaluation.
The anticonvulsant potential of chemical substances can be identified with test procedures that act at various biological levels, ranging from subcellular elements to the normal or modified intact animal. All of these procedures modify either some minimal overt threshold electrochemical or neurochemical event or a suprathreshold manifestation such as seizure spread. This suggests that laboratory tests for the detection, quantification, and evaluation of antiepileptic drugs should be designed to identify substances that elevate seizure threshold and/or prevent seizure spread. The s.c. Metrazol (pentylenetetrazol) seizure threshold test and the supramaximal electroshock seizure test are commonly used to achieve this objective. Additional chemoshock tests may be used to delineate further the mechanisms of anticonvulsant action. Numerous variables, such as experimental animals, electroshock apparatus, parameters of electrical and chemical stimulus, and routes of drug administration, must be controlled to ensure accurate, reliable, and reproducible results. The in vivo procedures described are reliable and reproducible, and predict clinical utility of the drugs tested. New models for testing anticonvulsant activity are evaluated against clinically effective antiepileptic drugs originally identified by these same procedures.
D000367:Age Factors; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001640:Bicuculline / Q000494:pharmacology; D001921:Brain / Q000187:drug effects; D003292:Convulsants / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004597:Electroshock; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy
D000927:Anticonvulsants; D003292:Convulsants; D010433:Pentylenetetrazole; D001640:Bicuculline